Experimental Study of Detection an Intentional Performance Degradation in Grip Strength
NCT ID: NCT02260999
Last Updated: 2014-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
136 participants
OBSERVATIONAL
2012-05-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychometric Measurement Properties of the Michigan Hand Questionnaire in Patients After Flexor Tendon Repair
NCT05093946
Influence of Wrist Taping on Handgrip Strength in Crossfit Athletes
NCT04780906
Proximal Strengthening for the Management of Wrist Pain
NCT02435979
Efficacy of Wrist/Hand Splints and Tendon/Nerve Gliding Exercises for Carpal Tunnel Syndrome: A RCT
NCT00336622
Grip Strength or Pinch Strength in Lateral Epicondylitis
NCT04206423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy
\> 18 years old sufficient language knowledge
No interventions assigned to this group
chronic pain patients
No interventions assigned to this group
patients with injury at the upper etxremity
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Christoph Maier, Prof. Dr.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christoph Maier, Prof. Dr.
Prof. Dr.med. C. Maier
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BHL-2113
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.